Resource

 

 

 

 

 

 

 

 

 

 

 

Hogan Lovells Represents Elastagen in Sale to Allergan

12 Feb 2018

Hogan Lovells represented Elastagen Pty Ltd., a clinical stage company developing medical device products based on recombinant tropoelastin, in its acquisition by Allergan, a leading global biopharmaceutical company.

Under the terms of the agreement, Sydney, Australia-based Elastagen will receive an upfront payment of about $95 million plus contingent payments of up to $165 million. Completion of the transition is subject to customary closing conditions, including review by Australia’s Foreign Investment Review Board.

Macfarlanes advises Hogg Robinson on recommended offer and simultaneous disposal of Fraedom division

12 Feb 2018

Macfarlanes has advised leading global B2B services company Hogg Robinson on a recommended offer by GBT, which trades as American Express Global Business Travel, for Hogg Robinson. The firm has also advised on the simultaneous class 1 disposal of Hogg Robinson’s Software-as-a-Service technology company Fraedom to Visa for approximately £140 million.

Macfarlanes advises Hogg Robinson on recommended offer and simultaneous disposal of Fraedom division

12 Feb 2018

Macfarlanes has advised leading global B2B services company Hogg Robinson on a recommended offer by GBT, which trades as American Express Global Business Travel, for Hogg Robinson. The firm has also advised on the simultaneous class 1 disposal of Hogg Robinson’s Software-as-a-Service technology company Fraedom to Visa for approximately £140 million.

Firm Advises on £200 Million Chinese Investment in Cambridge Science Park in UK

12 Feb 2018

A Squire Patton Boggs team, led by London Corporate partner Michelle Chen, has advised client Tus-Holdings Co., Ltd. on a landmark £200 million joint venture with Trinity College, Cambridge. The deal will see a new phase of investment and renewal in Cambridge Science Park, including 350,000 sq ft of office/research space over five new buildings, including a state-of-the-art Biohub, which will be home to laboratories and offices for early stage biotech and medtech companies.

WFW advises German asset and investment manager KGAL on acquisition of two French photovoltaic power plants

12 Feb 2018

Watson Farley & Williams (“WFW”) has advised KGAL, a leading independent asset and investment manager with an investment volume of €21.5bn across 87,000 investors, on all aspects of the acquisition of two project companies owning two French photovoltaic plants, with an overall installed capacity of 18.58 MW, from French developer Solairedirect. The WFW team also assisted KGAL on the negotiation of the project contracts with Solairedirect.

G+T advises on successful Paladin restructure and recapitalisation

12 Feb 2018

Paladin Energy Limited, an Australian listed company with substantial uranium and mining assets in Namibia, Malawi, Canada and certain Australian states, was placed into administration in July 2017 after one of its major customers, Electricité de France (EDF) advised Paladin it was not prepared to enter into a standstill agreement and required repayment of US$277 million under its Long Term Supply Agreement with the company. 

Petróleos Mexicanos Issues $4 Billion Offering

12 Feb 2018

Cleary Gottlieb is representing long-time client Petróleos Mexicanos (Pemex), the Mexican state oil company, in its $4 billion Rule 144A/Reg S debt offering with registration rights, and in two concurrent liability management transactions.

Pemex’s debt offering of 5.350 percent notes due 2028 and 6.350 percent bonds due 2048, under its medium-term notes program, launched and priced on February 1, 2018. The liability management transactions also launched simultaneously on February 1, 2018.